Cytodyn Inc (CYDY)

[Gernee20]

Not following this thread, just jumping in, but often times the company DOES see limited DSMB data. Really depends on how the trial is set up.

I’m in invested in another company. Ph2 trial in girls with Rett Syndrome. The placebo controlled trial was set up in a way where prior to the 20 patient enrollment target began, an additional 6 patients were first in enrolled, who were guaranteed to receive the drug, of which the DSMB reviewed this data to give the green light to enroll the final 20 patients. The company was privy to this data, and in fact, PR’d the DSMB review, they approved to continue the trial with no changes, and in this PR the company shared positive data.